← back to search

Nora Pashayan

MRC Epidemiology Unit · GB
Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Genetic Associations and Epidemiology, BRCA gene mutations in cancer, Global Cancer Incidence and Screening, and Prostate Cancer Diagnosis and Treatment.
h-index
51
citations
10,148
works
285
NIH funding
primary concept
email

Recent publications

Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in Canada
Communications Medicine 2026cited by 0position: lastdoi
Growth kinetics of high-grade serous ovarian cancer: implications for early detection
British Journal of Cancer 2025cited by 9position: lastdoi
Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meeting
BMC Medicine 2025cited by 4position: middledoi
Canadian Women’s Attitudes Toward Receiving Personalized Breast Cancer Risk Information: Insights From the PERSPECTIVE I&I Project
Clinical Breast Cancer 2025cited by 2position: middledoi
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality
JAMA 2024cited by 90position: middledoi
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis
EBioMedicine 2024cited by 44position: middledoi
A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer
Nature Communications 2024cited by 9position: middledoi
Risk-Adapted Breast Screening for Women at Low Predicted Risk of Breast Cancer: An Online Discrete Choice Experiment
Medical Decision Making 2024cited by 3position: middledoi
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
Nature Genetics 2023cited by 137position: middledoi
Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: a prospective cohort study
BMJ Oncology 2023cited by 44position: middledoi
Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study
PLoS Medicine 2023cited by 23position: middledoi
Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry
The American Journal of Human Genetics 2023cited by 23position: middledoi
The cost-effectiveness of risk-stratified breast cancer screening in the UK
British Journal of Cancer 2023cited by 23position: middledoi
REPRESENT recommendations: improving inclusion and trust in cancer early detection research
British Journal of Cancer 2023cited by 11position: middledoi
Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study
British Journal of Cancer 2023cited by 8position: middledoi
Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry
medRxiv 2023cited by 2position: middledoi
Natural history model predicts benefits associated with screening for lung cancer by detecting circulating tumor DNA
Research Square 2023cited by 0position: middledoi
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples
Nature Communications 2022cited by 50position: middledoi
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score
Prostate Cancer and Prostatic Diseases 2022cited by 38position: middledoi
Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention
Current Oncology 2022cited by 11position: middledoi
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Nature Genetics 2021cited by 492position: middledoi
The impact of the Covid-19 pandemic on breast cancer early detection and screening
Preventive Medicine 2021cited by 136position: middledoi
Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)
Journal of Personalized Medicine 2021cited by 131position: middledoi
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
Nature Communications 2021cited by 76position: middledoi
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer
Prostate Cancer and Prostatic Diseases 2021cited by 25position: middledoi
KLK3 SNP–SNP interactions for prediction of prostate cancer aggressiveness
Scientific Reports 2021cited by 15position: middledoi
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Nature Genetics 2021cited by 13position: middledoi
Alcohol Intake and Alcohol–SNP Interactions Associated with Prostate Cancer Aggressiveness
Journal of Clinical Medicine 2021cited by 9position: middledoi
Prostate cancer risk stratification improved across multiple ancestries with new polygenic hazard score
medRxiv 2021cited by 2position: middledoi
Personalized early detection and prevention of breast cancer: ENVISION consensus statement
Nature Reviews Clinical Oncology 2020cited by 431position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Kenneth Muir · Manchester Academic Health Science Centre4 papers (2017–2021)Rosalind A. Eeles · Meru University of Science and Technology4 papers (2017–2021)Julian Peto · London School of Hygiene & Tropical Medicine3 papers (2017–2019)Richard S. Houlston · Institute of Cancer Research3 papers (2017–2019)Clare Turnbull · Institute for Research in Schools3 papers (2017–2019)Frank Dudbridge · Universitätsmedizin Greifswald3 papers (2017–2022) · 3 papers (2017–2019)Alison M. Dunning · McMaster University3 papers (2017–2019)Robert Huddart · Institute of Cancer Research3 papers (2017–2019)Douglas F. Easton · Pacific Biomarkers (United States)3 papers (2017–2019)Zsofia Kote‐Jarai · Institute of Cancer Research3 papers (2017–2019)Peter Broderick · London School of Hygiene & Tropical Medicine3 papers (2017–2019)Nick Orr · Queen's University Belfast3 papers (2017–2019)Chey Loveday · Institute of Cancer Research3 papers (2017–2019)Paul D.P. Pharoah · University of Thessaly3 papers (2013–2025) · 3 papers (2017–2019)Kevin Litchfield · Cancer Research UK3 papers (2017–2019)Line Bjørge · University of Bergen2 papers (2018–2022)Nadia Harbeck · Universität Bayern2 papers (2018–2022)Martin Widschwendter · Universität Innsbruck2 papers (2018–2022)